Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Origin Vitae Network is a global healthcare organization specializing in regenerative medicine, longevity, and advanced cellular therapies. The company operates an international network of clinical centers that provide specialized treatments primarily utilizing umbilical cord-derived mesenchymal stem cells (UC-MSCs). Their protocols are designed to address a wide range of conditions, including autoimmune disorders, orthopedic injuries, and age-related degeneration, while also offering proactive wellness programs for performance optimization. By integrating cutting-edge stem cell research with personalized medical care, Origin Vitae aims to enhance human healthspan and treat chronic inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Origin Vitae Network.